The prognostic role of calretinin expression and neutrophil-to-lymphocyte ratio (NLR) in patients with malignant pleural mesothelioma (MPM) undergoing extrapleural pneumonectomy (EPP).

Authors

null

S. C. Kao

Asbestos Diseases Research Institute, Sydney, Australia

S. C. Kao , S. Klebe , D. Henderson , G. Reid , M. D. Chatfield , N. Armstrong , T. Yan , J. L. Vardy , S. J. Clarke , N. Van Zandwijk , B. McCaughan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Prognostic Factors

Citation

J Clin Oncol 29: 2011 (suppl; abstr 10545)

Abstract #

10545

Poster Bd #

21D

Abstract Disclosures

Similar Posters

Poster

2019 Gastrointestinal Cancers Symposium

The prognostic value of systemic inflammatory factors in BRAF (V600E) mutant metastatic colorectal cancer (mCRC).

The prognostic value of systemic inflammatory factors in BRAF (V600E) mutant metastatic colorectal cancer (mCRC).

First Author: Nieves Martinez Lago

Poster

2018 ASCO Annual Meeting

The value of inflammatory markers in predicting overall survival in older adults with cancer.

The value of inflammatory markers in predicting overall survival in older adults with cancer.

First Author: Tomohiro F. Nishijima

Poster

2018 Gastrointestinal Cancers Symposium

Malignant peritoneal mesothelioma: Clinicopathological features, prognostic factors, and survival outcomes.

Malignant peritoneal mesothelioma: Clinicopathological features, prognostic factors, and survival outcomes.

First Author: Meera Patel

Poster

2011 ASCO Annual Meeting

PI3K pathway and downstream signaling analysis in malignant pleural mesothelioma (MPM).

PI3K pathway and downstream signaling analysis in malignant pleural mesothelioma (MPM).

First Author: S. Cedres Perez